
    
      The VISUALISE AF study is a multi-center (global), open label, prospective, single arm study
      to establish the safety and effectiveness of the LUMINIZE RF Balloon Catheter System. The
      planned indication for use within the United States for LUMINIZE RF Balloon Catheter System
      is for the treatment of drug refractory, recurrent, symptomatic, Paroxysmal Atrial
      Fibrillation (PAF).

      All subjects fitting the enrollment criteria, signing the consent and undergoing the index
      procedure with the study devices will be followed up for one year.
    
  